ArticleFrontiers in global women's health2025
Prevalence and correlates of sexual intimate partner violence among trans women in the San Francisco Bay Area.
Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intimate partner violence (IPV), including sexual IPV, is a significant public health issue with serious mental, physical, and economic consequences. Trans women are disproportionately affected by sexual IPV. However, research on factors associated with sexual IPV is limited among trans women. This study seeks to identify factors associated with sexual IPV in a large cohort of trans women in the San Francisco Bay Area. Methods: We conducted a secondary data analysis of data from the Trans*National cohort study (2016-2017), which enrolled 629 trans women via respondent-driven sampling; we conducted bivariate and multivariable logistic regression analyses to examine correlates of lifetime history of sexual IPV. Results: The prevalence of lifetime sexual IPV was 36%, and bivariate analyses identified several factors associated with sexual IPV, including inconsistent hormone use, non-prescribed hormone use, sex work, polysubstance use, depression, posttraumatic stress disorder, suicidality, homelessness, and discrimination. Multivariable models revealed significant associations between sexual IPV and psychosocial factors, such as substance use, mental health diagnoses, and experiences of violence and discrimination. Conclusion: These findings are consistent with the substance abuse, violence, and HIV/AIDS syndemic framework, underscoring the interconnectedness of these conditions among trans women. In addition, the findings suggest that disruptions in access to gender-affirming care may be a negative consequence of sexual IPV. These results also highlight the urgent need for integrated approaches to address the mental health, substance use, and HIV prevention needs of trans women who experience sexual IPV. Interventions that address structural discrimination and provide holistic support are necessary to improve the health and wellbeing of trans women survivors of sexual IPV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.